vs
Side-by-side financial comparison of BILL Holdings, Inc. (BILL) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.
CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $414.7M, roughly 1.2× BILL Holdings, Inc.). BILL Holdings, Inc. runs the higher net margin — -0.6% vs -10.1%, a 9.5% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 14.4%). BILL Holdings, Inc. produced more free cash flow last quarter ($103.8M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 13.3%).
BILL Holdings, Inc. is an American company based in San Jose, California, that provides automated, cloud-based software for financial operations for small businesses in the United States. A white-labeled, end-to-end payments automation platform, Bill.com Connect is offered to financial institutions as part of their single sign-on online business banking ecosystem.
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
BILL vs CLOV — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $414.7M | $487.7M |
| Net Profit | $-2.6M | $-49.3M |
| Gross Margin | 79.8% | — |
| Operating Margin | -4.4% | -10.1% |
| Net Margin | -0.6% | -10.1% |
| Revenue YoY | 14.4% | 44.7% |
| Net Profit YoY | -107.7% | -123.2% |
| EPS (diluted) | $-0.03 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $414.7M | $487.7M | ||
| Q3 25 | $395.7M | $496.6M | ||
| Q2 25 | $383.3M | $477.6M | ||
| Q1 25 | $358.2M | $462.3M | ||
| Q4 24 | $362.6M | $337.0M | ||
| Q3 24 | $358.4M | $331.0M | ||
| Q2 24 | $343.7M | $356.3M | ||
| Q1 24 | $323.0M | $346.9M |
| Q4 25 | $-2.6M | $-49.3M | ||
| Q3 25 | $-3.0M | $-24.4M | ||
| Q2 25 | $-7.1M | $-10.6M | ||
| Q1 25 | $-11.6M | $-1.3M | ||
| Q4 24 | $33.5M | $-22.1M | ||
| Q3 24 | $8.9M | $-9.2M | ||
| Q2 24 | $7.6M | $7.4M | ||
| Q1 24 | $31.8M | $-19.2M |
| Q4 25 | 79.8% | — | ||
| Q3 25 | 80.5% | — | ||
| Q2 25 | 80.8% | — | ||
| Q1 25 | 81.2% | — | ||
| Q4 24 | 81.6% | — | ||
| Q3 24 | 82.0% | 24.5% | ||
| Q2 24 | 81.0% | 30.3% | ||
| Q1 24 | 83.0% | 23.6% |
| Q4 25 | -4.4% | -10.1% | ||
| Q3 25 | -5.2% | -4.9% | ||
| Q2 25 | -5.8% | -2.2% | ||
| Q1 25 | -8.1% | -0.3% | ||
| Q4 24 | -6.0% | -6.4% | ||
| Q3 24 | -2.1% | -2.7% | ||
| Q2 24 | -6.5% | 2.0% | ||
| Q1 24 | -8.6% | -6.5% |
| Q4 25 | -0.6% | -10.1% | ||
| Q3 25 | -0.7% | -4.9% | ||
| Q2 25 | -1.8% | -2.2% | ||
| Q1 25 | -3.2% | -0.3% | ||
| Q4 24 | 9.3% | -6.6% | ||
| Q3 24 | 2.5% | -2.8% | ||
| Q2 24 | 2.2% | 2.1% | ||
| Q1 24 | 9.8% | -5.5% |
| Q4 25 | $-0.03 | — | ||
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $0.02 | — | ||
| Q1 25 | $-0.11 | — | ||
| Q4 24 | $-0.06 | — | ||
| Q3 24 | $0.08 | — | ||
| Q2 24 | $0.37 | — | ||
| Q1 24 | $0.00 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1B | $78.3M |
| Total DebtLower is stronger | $1.8B | — |
| Stockholders' EquityBook value | $3.8B | $308.7M |
| Total Assets | $10.1B | $541.0M |
| Debt / EquityLower = less leverage | 0.48× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1B | $78.3M | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $1.6B | $194.5M | ||
| Q3 24 | $853.5M | $288.0M | ||
| Q2 24 | $985.9M | $254.8M | ||
| Q1 24 | $952.5M | $208.3M |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $914.8M | — | ||
| Q2 24 | $914.0M | — | ||
| Q1 24 | $1.1B | — |
| Q4 25 | $3.8B | $308.7M | ||
| Q3 25 | $3.9B | $340.9M | ||
| Q2 25 | $3.9B | $344.2M | ||
| Q1 25 | $3.9B | $336.1M | ||
| Q4 24 | $3.8B | $341.1M | ||
| Q3 24 | $4.0B | $342.2M | ||
| Q2 24 | $4.1B | $324.9M | ||
| Q1 24 | $4.1B | $292.5M |
| Q4 25 | $10.1B | $541.0M | ||
| Q3 25 | $10.2B | $559.7M | ||
| Q2 25 | $10.1B | $575.0M | ||
| Q1 25 | $9.6B | $583.7M | ||
| Q4 24 | $9.7B | $580.7M | ||
| Q3 24 | $9.0B | $653.0M | ||
| Q2 24 | $9.2B | $674.2M | ||
| Q1 24 | $9.1B | $671.8M |
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.44× | — | ||
| Q1 25 | 0.43× | — | ||
| Q4 24 | 0.44× | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.28× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $105.3M | $-66.9M |
| Free Cash FlowOCF − Capex | $103.8M | $-69.0M |
| FCF MarginFCF / Revenue | 25.0% | -14.1% |
| Capex IntensityCapex / Revenue | 0.4% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $378.8M | $-69.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $105.3M | $-66.9M | ||
| Q3 25 | $96.9M | $12.1M | ||
| Q2 25 | $83.8M | $5.4M | ||
| Q1 25 | $99.5M | $-16.3M | ||
| Q4 24 | $78.7M | $34.8M | ||
| Q3 24 | $88.6M | $50.0M | ||
| Q2 24 | $78.6M | $44.8M | ||
| Q1 24 | $66.8M | $25.9M |
| Q4 25 | $103.8M | $-69.0M | ||
| Q3 25 | $95.6M | $11.4M | ||
| Q2 25 | $81.0M | $4.8M | ||
| Q1 25 | $98.4M | $-16.5M | ||
| Q4 24 | $78.3M | $33.3M | ||
| Q3 24 | $88.6M | $49.6M | ||
| Q2 24 | $78.4M | $44.4M | ||
| Q1 24 | $66.8M | $25.5M |
| Q4 25 | 25.0% | -14.1% | ||
| Q3 25 | 24.1% | 2.3% | ||
| Q2 25 | 21.1% | 1.0% | ||
| Q1 25 | 27.5% | -3.6% | ||
| Q4 24 | 21.6% | 9.9% | ||
| Q3 24 | 24.7% | 15.0% | ||
| Q2 24 | 22.8% | 12.5% | ||
| Q1 24 | 20.7% | 7.3% |
| Q4 25 | 0.4% | 0.4% | ||
| Q3 25 | 0.3% | 0.1% | ||
| Q2 25 | 0.7% | 0.1% | ||
| Q1 25 | 0.3% | 0.0% | ||
| Q4 24 | 0.1% | 0.5% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.1% | 0.1% | ||
| Q1 24 | 0.0% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.35× | — | ||
| Q3 24 | 9.94× | — | ||
| Q2 24 | 10.35× | 6.04× | ||
| Q1 24 | 2.10× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BILL
| Accounts Payable And Accounts Receivable Solutions | $185.9M | 45% |
| Spend And Expense Interchange Revenue | $166.5M | 40% |
| Interest On Funds Held For Customers | $39.5M | 10% |
| Embedded And Other Solutions | $22.8M | 5% |
CLOV
Segment breakdown not available.
